Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Osamu Tohyama
Observed names:
O. Tohyama,
OSAMU TOHYAMA,
遠山治
Institution:
Eisai (Japan)
Observed institutions:
Kyoto University,
Eisai (United States),
Eisai (Japan)
OpenAlex ID:
A5046855521
Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane
2004
·
Akihiro Imura
, Akiko Iwano
, et al.
·
FEBS Letters
·
585
Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage
2014
·
Yuji Yamamoto
, Junji Matsui
, et al.
·
Vascular Cell
·
538
PDF
Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models
2014
·
Osamu Tohyama
, Junji Matsui
, et al.
·
Journal of Thyroid Research
·
503
PDF
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
2014
·
Yasuhiro Funahashi
, Kiyoshi Okamoto
, et al.
·
Cancer Science
·
279
PDF
Klotho Is a Novel β-Glucuronidase Capable of Hydrolyzing Steroid β-Glucuronides
2004
·
Osamu Tohyama
, Akihiro Imura
, et al.
·
Journal of Biological Chemistry
·
253
PDF
E7050: A dual c‐Met and VEGFR‐2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models
2009
·
Takayuki Nakagawa
, Osamu Tohyama
, et al.
·
Cancer Science
·
116
PDF
Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus
2017
·
Masahiro Matsuki
, Yusuke Adachi
, et al.
·
Cancer Science
·
68
PDF
Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti‐angiogenesis activity in a preclinical cancer model
2014
·
Youya Nakazawa
, Satoshi Kawano
, et al.
·
Cancer Science
·
40
PDF
Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor
2011
·
KIYOSHI OKAMOTO
, DAISUKE ITO
, et al.
·
International Journal of Molecular Medicine
·
11
PDF
Wif1 and Ifitm3 gene expression preferentially altered in the colon mucosa of benzo[a]pyrene pre-treated mice following exposure to dextran sulfate sodium
2015
·
Naoki Koyama
, Atsushi Hakura
, et al.
·
Chemico-Biological Interactions
·
7
Abstract 3264: Lenvatinib in combination with everolimus demonstrated enhanced antiangiogenesis and antitumor activity in human RCC xenograft models
2016
·
Yusuke Adachi
, Masahiro Matsuki
, et al.
·
Cancer Research
·
3
Abstract 2980: Maximizing the efficacy of anti-angiogenesis cancer therapy: A multi-targeting strategy by tyrosine kinase inhibitors
2014
·
Youya Nakazawa
, Satoshi Kawano
, et al.
·
Cancer Research
·
3
Clinical benefit of eribulin (Halaven®) in the treatment of advanced soft tissue sarcoma patients and the novel anti-tumor mechanisms
2016
·
Noriyuki Koyama
, Shigeru Taniguchi
, et al.
·
Folia Pharmacologica Japonica
·
2
PDF
The antitumor activity of lenvatinib (LEN) in combination with everolimus (EVE) in human renal cell carcinoma (RCC) xenograft models is dependent on VEGFR and FGFR signaling
2016
·
T. Kimura
, Y. Adachi
, et al.
·
Annals of Oncology
·
1
PDF
Abstract 3262: Effects of lenvatinib mesilate in combination with everolimus on VEGF and FGF-driven angiogenesis and tumor growth
2016
·
Kaoru Mitsuhashi
, Takayuki Kimura
, et al.
·
Cancer Research
·
1
Abstract 1371: Systems biology analysis to identify biomarkers for lenvatinib in the preclinical cancer cell line panels
2015
·
Zoltan Dezso
, Mitsuhiro Ino
, et al.
·
Cancer Research
·
1
悪性軟部腫瘍に対するエリブリンメシル酸塩(ハラヴェン静注1 mg)の臨床効果と抗腫瘍メカニズムについて
2016
·
小山則行
, 谷口茂
, et al.
·
Folia Pharmacologica Japonica
Abstract 1376: Receptor tyrosine kinase (RTK) signaling pathway in preclinical thyroid cancer models: Antitumor and antiangiogenic activity of lenvatinib to target VEGFR/FGFR/RET
2015
·
Osamu Tohyama
, Junji Matsui
, et al.
·
Cancer Research
Show more works
View as search
Works count:
18
Citation count:
2,411
H-index:
9
I10-index:
9
Year
Topic
Type